InvestorsHub Logo
Followers 5
Posts 480
Boards Moderated 0
Alias Born 05/01/2019

Re: band aid post# 5742

Thursday, 10/29/2020 9:59:29 AM

Thursday, October 29, 2020 9:59:29 AM

Post# of 13843
Quick clot Control has a class II FDA approval. Hemostyp was encouraged by FDA to seek PMA Class III approval. A more rigorous and lengthy (as we have witnessed) process. The payoff should be worth it.
This offer at 500 and JJ $400M offer for tachosil set a low bar for acquisitions.